Business integration between Kyorin Pharmaceutical Co., Ltd. and the Medical & Pharmaceutical Business Group of Teijin Ltd.Merger Agreement • January 23rd, 2003
Contract Type FiledJanuary 23rd, 2003Teijin Ltd. (Head Office: Chuo-ku, Osaka; President: Toru Nagashima; “Teijin”) and Kyorin Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo; President: Ikuo Ogihara; “Kyorin”) have reached a basic agreement that, scheduled for October 1, 2003, the Medical & Pharmaceutical Business Group of Teijin will be spun off and integrated into Kyorin, thus being developed as a key consolidated subsidiary of the Teijin Group. The newly integrated company will maintain its independent operation as a listed company.